ID: ALA537067

Max Phase: Preclinical

Molecular Formula: C21H15N5

Molecular Weight: 337.39

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  c1ccc(-c2ccc3c(Nc4ccc5[nH]ncc5c4)ccnc3c2)nc1

Standard InChI:  InChI=1S/C21H15N5/c1-2-9-22-18(3-1)14-4-6-17-20(8-10-23-21(17)12-14)25-16-5-7-19-15(11-16)13-24-26-19/h1-13H,(H,23,25)(H,24,26)

Standard InChI Key:  BCCAXOOXDXWSEE-UHFFFAOYSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 337.39Molecular Weight (Monoisotopic): 337.1327AlogP: 4.92#Rotatable Bonds: 3
Polar Surface Area: 66.49Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.16CX Basic pKa: 7.02CX LogP: 3.71CX LogD: 3.57
Aromatic Rings: 5Heavy Atoms: 26QED Weighted: 0.49Np Likeness Score: -1.59

References

1. Simon Townson and Suzanne Gokool. GlaxoSmithKline Published Kinase Inhibitor Set 2 Onchocerca lienalis Screening Data,  [10.6019/CHEMBL3988181]